Key | % Net Assets |
---|---|
![]() |
4.5% |
![]() |
4.4% |
![]() |
4.4% |
![]() |
4.0% |
![]() |
82.7% |
Name | % Net Assets |
---|---|
UBS | 4.5% |
Novartis | 4.4% |
BNP Paribas | 4.4% |
DnB NOR Bank | 4.0% |
Roche Holding | 3.8% |
Brenntag | 3.5% |
Hexagon | 3.5% |
Assa Abloy | 3.4% |
Svenska Cellulosa | 3.3% |
Henkel | 3.3% |
Key | % Net Assets |
---|---|
![]() | 20.00% |
![]() | 18.60% |
![]() | 17.50% |
![]() | 16.80% |
![]() | 16.50% |
Date | 27-Mar-2025 |
---|---|
NAV | 206.60p |
Currency | GBP |
Change | -3.10p |
% | -1.48% |
YTD change | 21.20p |
YTD % | 11.43% |
Fund Inception | 03/10/2003 |
---|---|
Fund Manager | Leon Howard-Spink |
TER | 1.68 (15-Mar-2012) |
Minimum Investment | |
---|---|
Initial | £1000 |
Additional | n/a |
Savings | £50 |
Charges | |
---|---|
Initial | n/a |
Annual Mang't | 1.50% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.02 |
Sharpe ratio | 0.15 |
You are here: research